The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61904-7 · Cited by 2,217
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,181
Molecular regulation of angiogenesis and lymphangiogenesis
Adams, R. H., & Alitalo, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2183 · Cited by 2,019
Self-citationBatchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Self-citationLymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
Self-citationKarkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421
Self-citationChemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,341
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., & Iruela-Arispe, M. L. (2007) · Cell · doi:10.1016/j.cell.2007.06.054 · Cited by 1,046
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2103 · Cited by 971
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Kindler, H. L., Niedzwiecki, D., Hollis, D., Sutherland, S., Schrag, D., Hurwitz, H., Innocenti, F., Mulcahy, M. F., O'Reilly, E., Wozniak, T. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1386 · Cited by 845
Angiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813
Self-citationMazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Mancuso, M. R., Davis, R., Norberg, S. M., O'Brien, S., Sennino, B., Nakahara, T., Yao, V. J., Inai, T., Brooks, P., Freimark, B., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24612 · Cited by 809
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Metastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041896 · Cited by 719
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase
Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake, K., Shibuya, M., Akira, S., Aburatani, H., & Maru, Y. (2008) · Nature Cell Biology · doi:10.1038/ncb1794 · Cited by 642
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009) · Nature Cell Biology · doi:10.1038/ncb1973 · Cited by 601
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581
Nagy, J. A., Vasile, E., Feng, D., Sundberg, C., Brown, L. F., Detmar, M. J., Lawitts, J. A., Benjamin, L., Tan, X., Manseau, E. J., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021244 · Cited by 559
Shields, J. D., Fleury, M. E., Yong, C., Tomei, A. A., Randolph, G. J., & Swartz, M. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.020 · Cited by 552
Spratlin, J. L., Cohen, R. B., Eadens, M., Gore, L., Camidge, D. R., Diab, S., Leong, S., O'Bryant, C., Chow, L. Q. M., Serkova, N. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7537 · Cited by 549
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
Self-citationVEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., & Detmar, M. (2007) · Blood · doi:10.1182/blood-2006-05-021758 · Cited by 533
Self-citationBlocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.018 · Cited by 532
Folkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 519
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M., & Swartz, M. A. (2010) · Science · doi:10.1126/science.1185837 · Cited by 506
Venneri, M. A., Palma, M. D., Ponzoni, M., Pucci, F., Scielzo, C., Zonari, E., Mazzieri, R., Doglioni, C., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-053504 · Cited by 505
Vascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
Kane, R. C., Farrell, A. T., Saber, H., Tang, S., Williams, G., Jee, J. M., Liang, C., Booth, B., Chidambaram, N., Morse, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1249 · Cited by 474
Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471
Self-citationSuppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902280106 · Cited by 471
Adnane, L., Trail, P. A., Taylor, I., & Wilhelm, S. M. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(05)07047-3 · Cited by 463
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Herbst, R. S., Sun, Y., Eberhardt, W. E., Germonpré, P., Saijo, N., Zhou, C., Wang, J., Li, L., Kabbinavar, F., Ichinose, Y., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70132-7 · Cited by 415
Hypoxia-driven selection of the metastatic phenotype
Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 410
He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T., & Alitalo, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4576 · Cited by 410
Self-citationSorensen, A. G., Batchelor, T. T., Zhang, W.-T., Chen, P.-J., Yeo, P., Wang, M., Jennings, D., Wen, P. Y., Lahdenranta, J., Ancukiewicz, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0814 · Cited by 394
Harrell, M. I., Iritani, B. M., & Ruddell, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060761 · Cited by 388
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., & Suda, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081605 · Cited by 388
Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387
Baffert, F., Le, T., Sennino, B., Thurston, G., Kuo, C. J., Hu-Lowe, D., & McDonald, D. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00616.2005 · Cited by 374
Partanen, J., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373
Self-citationAntiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371
Ebos, J. M. L., Lee, C. R., Christensen, J. G., Mutsaers, A. J., & Kerbel, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708148104 · Cited by 367
Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1392 · Cited by 361
An overview of small-molecule inhibitors of VEGFR signaling
Ivy, S. P., Wick, J. Y., & Kaufman, B. M. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.130 · Cited by 350
Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
Caunt, M., Mak, J., Liang, W.-C., Stawicki, S., Pan, Q., Tong, R. K., Kowalski, J., Ho, C., Reslan, H. B., Ross, J., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.029 · Cited by 343
Coffelt, S. B., Tal, A. O., Scholz, A., De Palma, M., Patel, S., Urbich, C., Biswas, S. K., Murdoch, C., Plate, K. H., Reiss, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0012 · Cited by 343
Angiopoietin-2 Causes Pericyte Dropout in the Normal Retina
Hammes, H.-P., Lin, J., Wagner, P., Feng, Y., vom Hagen, F., Krzizok, T., Renner, O., Breier, G., Brownlee, M., & Deutsch, U. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1104 · Cited by 342
Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3
Xu, Y., Yuan, L., Mak, J., Pardanaud, L., Caunt, M., Kasman, I., Larrivée, B., del Toro, R., Suchting, S., Medvinsky, A., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200903137 · Cited by 339
Self-citationVisualizing extravasation dynamics of metastatic tumor cells
Stoletov, K., Kato, H., Zardouzian, E., Kelber, J., Yang, J., Shattil, S., & Klemke, R. (2010) · Journal of Cell Science · doi:10.1242/jcs.069443 · Cited by 333
Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., & De Palma, M. (2009) · Blood · doi:10.1182/blood-2009-01-200931 · Cited by 328
Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2
Murdoch, C., Tazzyman, S., Webster, S., & Lewis, C. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7405 · Cited by 318
Roberts, N., Kloos, B., Cassella, M., Podgrabinska, S., Persaud, K., Wu, Y., Pytowski, B., & Skobe, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1843 · Cited by 315
Pathways mediating VEGF-independent tumor angiogenesis
Ferrara, N. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.003 · Cited by 313
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Kim, E. S., Serur, A., Huang, J., Manley, C. A., McCrudden, K. W., Frischer, J. S., Soffer, S. Z., Ring, L., New, T., Zabski, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398399 · Cited by 312
De Palma, M., Mazzieri, R., Politi, L. S., Pucci, F., Zonari, E., Sitia, G., Mazzoleni, S., Moi, D., Venneri, M. A., Indraccolo, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.004 · Cited by 301
Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors
Karpanen, T., Heckman, C. A., Keskitalo, S., Jeltsch, M., Ollila, H., Neufeld, G., Tamagnone, L., & Alitalo, K. (2006) · The FASEB Journal · doi:10.1096/fj.05-5646com · Cited by 299
Self-citationLin, J., Lalani, A. S., Harding, T. C., Gonzalez, M., Wu, W.-W., Luan, B., Tu, G. H., Koprivnikar, K., VanRoey, M. J., He, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0408 · Cited by 269
Self-citationAllegra, C. J., Yothers, G., O'Connell, M. J., Sharif, S., Colangelo, L. H., Lopa, S. H., Petrelli, N. J., Goldberg, R. M., Atkins, J. N., Seay, T. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9220 · Cited by 262
Molecular Control of Lymphatic Metastasis
Achen, M. G., & Stacker, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.020 · Cited by 260
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T. H., Griffiths, J., Ioffe, E., Daly, T. J., Fandl, J. P., Papadopoulos, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607538103 · Cited by 251
Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
Hashizume, H., Falcón, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D., Bready, J. V., Oliner, J. D., & McDonald, D. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1977 · Cited by 251
Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling
Makanya, A. N., Hlushchuk, R., & Djonov, V. G. (2009) · Angiogenesis · doi:10.1007/s10456-009-9129-5 · Cited by 243
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3567 · Cited by 241
Self-citationHerbst, R. S., Hong, D., Chap, L., Kurzrock, R., Jackson, E., Silverman, J. M., Rasmussen, E., Sun, Y.-N., Zhong, D., Hwang, Y. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6683 · Cited by 241
Lee, S. L. C., Rouhi, P., Jensen, L. D., Zhang, D., Ji, H., Hauptmann, G., Ingham, P., & Cao, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909228106 · Cited by 240
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
Tammela, T., Saaristo, A., Lohela, M., Morisada, T., Tornberg, J., Norrmén, C., Oike, Y., Pajusola, K., Thurston, G., Suda, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3327 · Cited by 236
Self-citationLocal Guidance of Emerging Vessel Sprouts Requires Soluble Flt-1
Chappell, J. C., Taylor, S. M., Ferrara, N., & Bautch, V. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.011 · Cited by 225
Falcón, B. L., Hashizume, H., Koumoutsakos, P., Chou, J., Bready, J. V., Coxon, A., Oliner, J. D., & McDonald, D. M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090391 · Cited by 224
Karlan, B. Y., Oza, A. M., Richardson, G. E., Provencher, D. M., Hansen, V. L., Buck, M., Chambers, S. K., Ghatage, P., Pippitt, C. H., Brown, J. V., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.3178 · Cited by 224
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Ojalvo, L. S., King, W., Cox, D., & Pollard, J. W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 221
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., & Augustin, H. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1615 · Cited by 201
Haiko, P., Makinen, T., Keskitalo, S., Taipale, J., Karkkainen, M. J., Baldwin, M. E., Stacker, S. A., Achen, M. G., & Alitalo, K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02214-07 · Cited by 198
Self-citationIssa, A., Le, T. X., Shoushtari, A. N., Shields, J. D., & Swartz, M. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1875 · Cited by 195
Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting
Wirzenius, M., Tammela, T., Uutela, M., He, Y., Odorisio, T., Zambruno, G., Nagy, J. A., Dvorak, H. F., Ylä-Herttuala, S., Shibuya, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062642 · Cited by 193
Self-citationDefective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice
Dellinger, M., Hunter, R., Bernas, M., Gale, N., Yancopoulos, G., Erickson, R., & Witte, M. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.04.024 · Cited by 190
VE-PTP controls blood vessel development by balancing Tie-2 activity
Winderlich, M., Keller, L., Cagna, G., Broermann, A., Kamenyeva, O., Kiefer, F., Deutsch, U., Nottebaum, A. F., & Vestweber, D. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811159 · Cited by 189
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 188
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.30 · Cited by 184
Self-citationNasarre, P., Thomas, M., Kruse, K., Helfrich, I., Wolter, V., Deppermann, C., Schadendorf, D., Thurston, G., Fiedler, U., & Augustin, H. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3030 · Cited by 181
The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors.
Dumont, D., Gradwohl, G., Fong, G.-H., Auerbach, R., & Breitman, M. L. (1993) · PubMed · Cited by 181
Structural determinants of growth factor binding and specificity by VEGF receptor 2
Leppänen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., Lankinen, H., Goldman, A., Ballmer-Hofer, K., & Alitalo, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914318107 · Cited by 177
Self-citationBry, M., Kivelä, R., Holopainen, T., Anisimov, A., Tammela, T., Soronen, J., Silvola, J. M. U., Saraste, A., Jeltsch, M., Korpisalo, P., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.957332 · Cited by 170
Self-citationKyzas, P. A., Geleff, S., Batistatou, A., Agnantis, N. J., & Stefanou, D. (2005) · The Journal of Pathology · doi:10.1002/path.1776 · Cited by 168
Lin, E. Y., Li, J.-F., Bricard, G., Wang, W., Deng, Y., Sellers, R., Porcelli, S. A., & Pollard, J. W. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.10.003 · Cited by 168
Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
Burton, J. B., Priceman, S. J., Sung, J. L., Brakenhielm, E., An, D. S., Pytowski, B., Alitalo, K., & Wu, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1488 · Cited by 167
Self-citationKoh, Y. J., Kim, H.-Z., Hwang, S.-I., Lee, J. E., Oh, N., Jung, K., Kim, M., Kim, K. E., Kim, H., Lim, N. K., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.001 · Cited by 166
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 163
Imaging angiogenesis and the microenvironment
FUKUMURA, D., & JAIN, R. K. (2008) · APMIS · doi:10.1111/j.1600-0463.2008.01148.x · Cited by 162
Xu, L., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., Samuel, R., Shellito, P., Czito, B. G., Lin, P.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2099 · Cited by 161
Coxon, A., BREADY, J. V., Min, H., Kaufman, S., Leal, J., Yu, D., Lee, T. A., Sun, J.-R., Estrada, J., Bolon, B. N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0213 · Cited by 158
Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules
Baffert, F., Le, T., Thurston, G., & McDonald, D. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00542.2005 · Cited by 157
Wong, S. Y., Haack, H., Crowley, D. G., Barry, M., Bronson, R. T., & Hynes, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0901 · Cited by 154
Brown, J. L., Cao, Z. A., Pinzon-Ortiz, M. C., Kendrew, J., Reimer, C., Wen, S., Zhou, J. Q., Tabrizi, M. A., Emery, S. C., McDermott, B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0554 · Cited by 154
Zhang, L., Zhou, F., Han, W., Shen, B., Luo, J., Shibuya, M., & He, Y. (2010) · Cell Research · doi:10.1038/cr.2010.116 · Cited by 152
Wu, Y. L., Zhong, Z., Huber, J., Bassi, R., Finnerty, B., Corcoran, E., Li, H., Navarro, E. C., Balderes, P. J., Jimenez, X., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0831 · Cited by 152
Palma, M. D., Venneri, M. A., Galli, R., Sergi, L., Politi, L., Sampaolesi, M., & Naldini, L. (2005) · Lirias · doi:10.1016/j.ccr.2005.08.0052 · Cited by 151
Murakami, M., Zheng, Y., Hirashima, M., Suda, T., Morita, Y., Ooehara, J., Ema, H., Fong, G., & Shibuya, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150433 · Cited by 143
Huang, H., Lai, J.-Y., Do, J., Liu, D., Li, L., Rosario, J. D., Doppalapudi, V. R., Pirie-Shepherd, S. R., Levin, N., Bradshaw, C. W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2317 · Cited by 142
Zhang, J., Fukuhara, S., Sako, K., Takenouchi, T., Kitani, H., Kume, T., Koh, G. Y., & Mochizuki, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192641 · Cited by 136
Tvorogov, D., Anisimov, A., Zheng, W., Leppänen, V., Tammela, T., Laurinavičius, S., Holnthoner, W., Heloterä, H., Holopainen, T., Jeltsch, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.001 · Cited by 135
Self-citationChae, S.-S., Kamoun, W. S., Farrar, C. T., Kirkpatrick, N. D., Niemeyer, E., de Graaf, A. M. A., Sorensen, A. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3073 · Cited by 135
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134
di Tomaso, E., Capen, D. E., Haskell, A., Hart, J., Logie, J. J., Jain, R. K., McDonald, D. M., Jones, R. C., & Munn, L. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4552 · Cited by 119
Gerber, H., Wu, X., Yu, L., Wiesmann, C., Liang, X. H., Lee, C. V., Fuh, G., Olsson, C., Damico, L. A., Xie, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611492104 · Cited by 118
Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?
Cutsem, E. V., Lambrechts, D., Prenen, H., Jain, R. K., & Carmeliet, P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2701 · Cited by 113
Rofstad, E. K., Tunheim, S. H., Mathiesen, B. S., Graff, B. A., Halsør, E. F., Nilsen, K., & Galappathi, K. (2002) · PubMed · Cited by 106
Cao, Y., Sonveaux, P., Liu, S., Zhao, Y., Mi, J., Clary, B. M., Li, C., Kontos, C. D., & Dewhirst, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4056 · Cited by 101
Mita, A. C., Takimoto, C. H. M., Mita, M. M., Tolcher, A. W., Sankhala, K. K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3368 · Cited by 101
Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma
Schmidinger, M., & Joaquim Bellmunt, B. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.01.003 · Cited by 98
Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
Bagri, A., Kouros‐Mehr, H., Leong, K. G., & Plowman, G. D. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.004 · Cited by 94
How do angiopoietins Tie with vascular endothelial growth factors?
Saharinen, P., Bry, M., & Alitalo, K. K. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283386673 · Cited by 91
Self-citationSalmon, A. H. J., Neal, C. R., Sage, L. M., Glass, C. A., Harper, S. J., & Bates, D. O. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp093 · Cited by 90
Twardowski, P. W., Stadler, W. M., Frankel, P. H., Lara, P. N., Ruel, C., Chatta, G. S., Heath, E. I., Quinn, D. I., & Gandara, D. R. (2010) · Urology · doi:10.1016/j.urology.2010.04.025 · Cited by 88
Basal and angiopoietin-1–mediated endothelial permeability is regulated by sphingosine kinase-1
Li, X., Stankovic, M., Bonder, C. S., Hahn, C. N., Parsons, M., Pitson, S. M., Xia, P., Proia, R. L., Vadas, M. A., & Gamble, J. R. (2008) · Blood · doi:10.1182/blood-2007-05-092148 · Cited by 88
Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice
Qu, X., Tompkins, K. L., Batts, L. E., Puri, M. C., Baldwin, H. S., & Baldwin, S. (2010) · Development · doi:10.1242/dev.043380 · Cited by 86
Loss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report
D’Amico, G., Korhonen, E. A., Waltari, M., Saharinen, P., Laakkonen, P., & Alitalo, K. K. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196618 · Cited by 85
Self-citationKandel (1992) · International Journal of Oncology · doi:10.3892/ijo_00000131 · Cited by 81
Shibata, M.-A., Morimoto, J., Shibata, E., & Otsuki, Y. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.43 · Cited by 72
Holopainen, T., Huang, H., Chen, C., Kim, K. E., Zhang, L., Zhou, F., Han, W., Li, C., Yu, J., Wu, J. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4654 · Cited by 72
Self-citationAngiopoietin-2-Driven Vascular Remodeling in Airway Inflammation
Tabruyn, S. P., Colton, K., Morisada, T., Fuxe, J., Wiegand, S. J., Thurston, G., Coyle, A. J., Connor, J. R., & McDonald, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100059 · Cited by 71
Real-time Imaging of Lymphogenic Metastasis in Orthotopic Human Breast Cancer
Dadiani, M., Kalchenko, V., Yosepovich, A., Margalit, R., Hassid, Y., Degani, H., & Seger, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0728 · Cited by 70
Korsisaari, N., Kasman, I. M., Forrest, W. F., Pal, N., Bai, W., Fuh, G., Peale, F. V., Jr., Smits, R., & Ferrara, N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704213104 · Cited by 65
Korsisaari, N., Ross, J., Wu, X., Kowanetz, M., Pal, N., Hall, L., Eastham‐Anderson, J., Forrest, W. F., van Bruggen, N., Peale, F. V., Jr., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1552 · Cited by 62
Sarraf‐Yazdi, S., Mi, J., Moeller, B. J., Niu, X.-L., White, R. R., Kontos, C. D., Sullenger, B. A., Dewhirst, M. W., & Clary, B. M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.028 · Cited by 61
Yu, Y., Lee, P., Ke, Y., Yongke, Z., Qiu, Y., Lee, J., Li, M., Jialiang, S., Chen, J., Dai, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009072 · Cited by 58
Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Tumor-Induced Lymph Flow
Ruddell, A., Harrell, M. I., Minoshima, S., Maravilla, K. R., Iritani, B. M., White, S. W., & Partridge, S. C. (2008) · Neoplasia · doi:10.1593/neo.08342 · Cited by 54
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin‐2
Reiss, Y., Knedla, A., Tal, A. O., Schmidt, M. H. H., Jugold, M., Kiessling, F. M., Burger, A. M., Wolburg, H., Deutsch, U., & Plate, K. H. (2008) · The Journal of Pathology · doi:10.1002/path.2484 · Cited by 53
Pathak, A. P., Artemov, D., Neeman, M., & Bhujwalla, Z. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1788 · Cited by 51
Jang, C., Koh, Y. J., Lim, N. K., Kang, H. J., Kim, D. H., Park, S. K., Lee, G. M., Jeon, C. J., & Koh, G. Y. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.172676 · Cited by 49
Double target for tumor mass destruction
Saharinen, P., & Alitalo, K. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18539 · Cited by 48
Self-citationAngiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer
Szarvas, T., Jäger, T., Tötsch, M., Dorp, F. V., Kempkensteffen, C., Kovalszky, I., Romics, I., Ergün, S., & Rubben, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0677 · Cited by 44
Koch, M., Dettori, D., Nuffelen, A. V., Souffreau, J., Marconcini, L., Wallays, G., Moons, L., Bruyére, F., Oliviero, S., Noël, A., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2605 · Cited by 44
Wang, F., Barfield, E., Dutta, S., Pua, T. L., & Fishman, D. A. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.08.019 · Cited by 42
Li, Z., Huang, H., Boland, P. S., Dominguez, M. G., Burfeind, P., Lai, K. V., Lin, H.-C., Gale, N. W., Daly, C., Auerbach, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911189106 · Cited by 35
Kendrew, J., Eberlein, C., Hedberg, B., McDaid, K., Smith, N. R., Weir, H. M., Wedge, S. R., Blakey, D. C., Foltz, I. N., Zhou, J. Q., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0876 · Cited by 33
Complex Biotransformations Catalyzed by Radical S-Adenosylmethionine Enzymes
Zhang, Q., & Liu, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.272690 · Cited by 25
Rosen, L. S., Mendelson, D. S., Cohen, R. B., Gordon, M. S., Goldman, J. W., Bear, I. K., Byrnes, B., Perea, R., Schoenfeld, S., & Gollerkeri, A. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2524 · Cited by 22
Hwang, J.-A., Lee, E. H., Kim, H., Park, J. B., Jeon, B. H., & Cho, C. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0041 · Cited by 19
Immunohistochemical demonstration of Angiopoietin-2 in lymphatic vascular development
Shimoda, H. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0513-9 · Cited by 16
New Antibody to Stop Tumor Angiogenesis and Lymphatic Spread by Blocking Receptor Partnering
McDonald, D. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.030 · Cited by 9
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,269
Fagiani, E., & Christofori, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 676
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Self-citationMetabolic Regulation of Macrophage Polarization in Cancer
Mehla, K., & Singh, P. K. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.10.007 · Cited by 617
Metadata
- Authors
- Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 17
- Issue
- 7
- Pages
- 347-362
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2080997194
- Cited by
- 478
- References
- 189
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.